Company News for May 18, 2011 - Corporate Summary

Loading...
Loading...

•    Dell Inc.
DELL
reported Q1 EPS of $0.55, higher than the Zacks Consensus Estimate of $0.43 per share. Revenue for the quarter edged up 1% year-over-year to $15.02 billion, falling short of the Zacks Consensus Estimate of $15.457 billion


•    Share prices of US listed Allied Irish Banks, PLC.
AIB
rose 13.33% to close at $3.06 after the banking company unveiled a new structure and top management team


•    Leerink Swann initiated coverage on shares of Anthera Pharmaceuticals, Inc.
ANTH
with an "Outperform" rating and a valuation call of $12 to $14 per share


•    Share prices of elong, Inc.
LONG
increased 56.72% on news that China‘s Tencent Holdings has bought a 16% stake in the company for $84.4 million


•    Shares of FairPoint Communications, Inc.
FRP
fell more than 40% to close at $9.59. Although the company posted first quarter profits, its revenues were flat compared to the prior year

Loading...
Loading...

•    Analysts at Madison Williams initiated coverage on Linn Energy, LLC
LINE
with a “Buy” rating and a target price of $45.00


•    Analysts at Goldman Sachs
GS
initiated coverage on MAKO Surgical
MAKO
with a “Buy” rating


•    Analysts at Boenning & Scattergood initiated coverage on Nektar Therapeutics
NKTR
with an “Outperform” rating and a target price of $15.00


•    Analysts at Oppenheimer analysts initiated coverage on Oncolytics Biotech, Inc.
ONCY
setting a “perform” rating


•    Analysts at ThinkEquity initiated coverage on Optimer Pharmaceuticals, Inc.
OPTR
with a “Buy” rating and a target price of $18.00


ALLIED IRISH BK (AIB): Free Stock Analysis Report

ANTHERA PHARMA (ANTH): Free Stock Analysis Report

DELL INC (DELL): Free Stock Analysis Report

GOLDMAN SACHS (GS): Free Stock Analysis Report

LINN ENERGY LLC (LINE): Free Stock Analysis Report

ELONG INC-ADR (LONG): Free Stock Analysis Report

MAKO SURGICAL (MAKO): Free Stock Analysis Report

NEKTAR THERAP (NKTR): Free Stock Analysis Report

ONCOLYTICS BIO (ONCY): Free Stock Analysis Report

OPTIMER PHARMAC (OPTR): Free Stock Analysis Report

Zacks Investment Research
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...